I can not believe the market has got this stock right.
Sure, it is expanding with new acquisitions. It is consolidating a fractured market in medical instruments and supplies, so the opportunities are huge. Sure, the results are uncertain. But it has already reported 7% organic growth +acquisitions and cross-selling. A Hong Kong company has brought 15% of the company at 89 cents per share. This wil fund further expansion. Its cash flow will be impressive. The market price is 68 cents! (30% difference). Analysts est 7.1c earnings FY19 (fPE <10).
This company had its first profitable seven or eight years ago, and it keeps growing. With the new entrant, the company will be soon be captialised over $300m, making it eligible for the ASX200. That means other analysts will follow, and it will move into the highly traded.
I see this stock over $1 ps within twelve months. That's 40% return.
What do you think?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
0.005(1.25%) |
Mkt cap ! $670.3M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.5¢ | 39.0¢ | $138.7K | 346.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 37586 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 840 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| PGC (ASX) Chart |